A team led by Boeing Phantom Works is to modify the ScanEagle unmanned air vehicle to look for biological warfare agents under a demonstration funded by the US Defense Threat Reduction Agency.
In flight tests late next year, two ScanEagle UAVs equipped with a remote sensor system will be operated from US Navy research ships to locate, track, collect and detect simulated biological warfare agents, to demonstrate the ability to determine whether a target has biological or chemical agents present.
The initial $8.2 million demonstration contract includes options valued at $15 million for further development and limited production of up to eight air vehicles. The Insitu-designed ScanEagle is now being used by the US Navy and Marine Corps in Iraq under services contracts with Boeing.
For exclusive news and expert analysis every week subscribe to Flight International print edition. Included with your subscription are 4 FREE issues and FREE delivery to your home or office.
Australia signs $12.7m UAV lease contract
(21/11/06)
ScanEagle trials go on
(15/11/05)